SCHEMBL378893

SCHEMBL378893

Cc1ccc(NC(=O)O)cc1NC(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.55
ALDH1A1 P00352 3/20 0.55
NPC1 O15118 5/20 0.54
RAB9A P51151 4/20 0.54
NPSR1 Q6W5P4 2/20 0.54
RXFP1 Q9HBX9 1/20 0.54
KMT2A Q03164 6/20 0.51
LMNA P02545 3/20 0.51
MEN1 O00255 3/20 0.51
ATM Q13315 1/20 0.51
POLB P06746 2/20 0.50
MAPK1 P28482 1/20 0.47
CYP1A2 P05177 1/20 0.45
DDX3X O00571 1/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
FKBP5 Q13451 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30050717 1.00 MAPT (0.55) MAPTALDH1A1NPC1RAB9ANPSR1
Hydrochloric Acid SCHEMBL11406931 0.98 MAPT (0.53) MAPTALDH1A1NPC1RAB9ANPSR1
SCHEMBL12937737 0.90 KMT2A (0.57) MAPTALDH1A1NPC1RAB9ANPSR1
SCHEMBL31267143 0.87 HPGD (0.51) MAPTALDH1A1NPC1RAB9ANPSR1
SCHEMBL18209634 0.87 HPGD (0.51) MAPTALDH1A1NPC1RAB9ANPSR1
SCHEMBL22210642 0.86 RAB9A (0.51) MAPTALDH1A1NPC1RAB9ANPSR1
SCHEMBL9926717 0.83 NPC1 (0.44) MAPTALDH1A1NPC1RAB9ANPSR1
SCHEMBL7563975 0.83 NLRP3 (0.58) MAPTALDH1A1NPC1RAB9AKMT2A
SCHEMBL3012871 0.83 POLB (0.70) MAPTALDH1A1NPC1RAB9AKMT2A
SCHEMBL4299638 0.82 POLB (0.49) MAPTALDH1A1NPC1RAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023161645-A2 PHARMACEUTICAL COMPOSITIONS FOR VAPORIZATION AND INHALATION GROW BIOTECH PLC (GB) 2023-08-31 WO claimed
CN-113024418-B Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source 河北工业大学 2023-01-24 CN claimed
EP-3630717-B1 A PROCESS FOR THE SYNTHESIS OF AROMATIC CARBAMATES COUNCIL SCIENT IND RES (IN) 2022-02-09 EP claimed
EP-2592069-B1 METHOD OF PRODUCING TOLUENEDICARBAMATE AND METHOD OF PRODUCING TOLUENEDIISOCYANATE MITSUI CHEMICALS INC (JP) 2019-04-24 EP claimed
US-8742164-B2 Method for producing toluenedicarbamate, method for producing toluenediisocyanate, and toluenedicarbamate MITSUI CHEMICALS, INC. (JP) 2014-06-03 US claimed
US-20140087207-A1 ARTICLES COMPRISING A WEATHER-RESISTANT ADHESIVE LAYER IN CONTACT WITH A LOW SURFACE-ENERGY MATERIAL DU PONT (US) 2014-03-27 US claimed
EP-2592069-A1 METHOD OF PRODUCING TOLUENEDICARBAMATE, METHOD OF PRODUCING TOLUENEDIISOCYANATE, AND TOLUENEDICARBAMATE Mitsui Chemicals, Inc. (JP) 2013-05-15 EP claimed
US-20130109881-A1 METHOD FOR PRODUCING TOLUENEDICARBAMATE, METHOD FOR PRODUCING TOLUENEDIISOCYANATE, AND TOLUENEDICARBAMATE MITSUI CHEMICALS, INC. 2013-05-02 US claimed
EP-1420013-B1 Process for hydrogenating aromatic urethanes in the presence of a supported ruthenium catalyst EVONIK DEGUSSA GMBH (DE) 2008-04-02 EP claimed
EP-1420012-B1 Process for the preparation of aliphatic isocyanates from aromatic isocyanates DEGUSSA (DE) 2006-11-02 EP claimed
EP-1362901-B1 Thermoset adhesive films NAT STARCH CHEM INVEST (US) 2006-03-15 EP claimed
US-20050137340-A1 Thermoset adhesive films NIKOLIC NIKOLA A (US) 2005-06-23 US claimed
EP-1420012-A1 Process for the preparation of aliphatic isocyanates from aromatic isocyanates Degussa AG (DE) 2004-05-19 EP claimed
EP-1420013-A1 Process for hydrogenating aromatic urethanes in the presence of a supported ruthenium catalyst Degussa AG (DE) 2004-05-19 EP claimed
EP-1362901-A2 Thermoset adhesive films National Starch and Chemical Investment Holding Corporation (US) 2003-11-19 EP claimed
US-4081472-A CATALYTIC, FROM A CARBAMATE MITSUI TOATSU CHEMICALS INC. (JA) 1978-03-28 US claimed
US-3962302-A Production of isocyanates from esters of carbamic acids (urethanes) ATLANTIC RICHFIELD COMPANY (US) 1976-06-08 US claimed
CN-117866376-A Polyacetal resin composition 旭化成株式会社 2024-04-12 CN disclosed
US-3968092-A Use of aromatic furfuryl polycarbamates as chloroprene polymer vulcanization accelerators E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-07-06 US disclosed
US-3962302-A Production of isocyanates from esters of carbamic acids (urethanes) ATLANTIC RICHFIELD COMPANY (US) 1976-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109881-A1 METHOD FOR PRODUCING TOLUENEDICARBAMATE, METHOD FOR PRODUCING TOLUENEDIISOCYANATE, AND TOLUENEDICARBAMATE CPS1, TST, ALKBH3 MAPT 1636/4885ALDH1A1 396/4885NPC1 2232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.